Midcap picks for intra-day trades from Geojit BNP Paribas

Here are a few intra-day trading strategies from Geojit BNP Paribas for trade today:

BUY JUBILANT LIFE SCIENCES (Rs 416.50)

Support at Rs 411 below Rs 408.10. Resistance is at Rs 422 above Rs 428.75. (Buy for intraday with a stoploss below Rs 408.10)

[VOLUME JUMP + STOCHASTICS BUY + ABV MOVING AVERAGES + NEW HIGH]

BUY UFLEX (Rs 187.90)

Support at Rs 183.50 below 181.50. Resistance is at Rs 191.35 above Rs 194.55. (Buy for intraday with a stoploss below Rs 181.50)

[ABV MOVING AVERAGES + MACD & STOCHASTICS BUY + VOLUME JUMP]

BUY KPR MILL (Rs 821.60)

Support at Rs 811 below Rs 809.10. Resistance is at Rs 832 above Rs 839.60. (Buy for intraday with a stoploss below Rs 809.10)
 
[VOLUME JUMP + STOCHASTICS BUY + ABV MOVING AVERAGES]

BUY ELECON ENGINEERING COMPANY (Rs 83.25)

Support at Rs 81 below Rs 79.50. Resistance is at Rs 85.25 above Rs 87.40. (Buy for intraday with a stoploss below Rs 79.50)

[MACD & STOCHASTICS BUY + VOLUME JUMP + ABV MOVING AVERAGES]

BUY KRBL (Rs 209.95)

Support at Rs 205.50 below Rs 203.20. Resistance is at Rs 214.35 above Rs 218. (Buy for intraday with a stoploss below Rs 203.20)

[VOLUME JUMP + ABV MOVING AVERAGES + MACD & STOCHASTICS BUY + NEW HIGH]

Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.